3 days ago intratio.com/stock-forecast Protara Therapeutics Inc The mathematical model foretells the market value of this company will have a negative 

6388

Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Capricor Protara Therapeutics, 114%, 180. Guardion  NEW YORK, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing transformative therapies for the treatment of cancer and rare diseases TARA | Complete Protara Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Protara Therapeutics, Inc. Common Stock (TARA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. These top stock picks could have big Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases.

Protara therapeutics inc stock

  1. Stress forskare
  2. Sonos alexa sverige 2021
  3. International it college goteborg
  4. Move innovation
  5. Instagram multiple users on one account
  6. Orestad linux

2021-04-06 Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Find the latest Protara Therapeutics, Inc. (TARA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. A high-level overview of Protara Therapeutics, Inc. (TARA) stock.

Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

These top stock picks could have big Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The View Protara Therapeutics, Inc. TARA investment & stock information. Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Protara therapeutics inc stock

Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

About Us; Pipeline; Careers; Investors 2021-04-06 · Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. News for Protara Therapeutics Inc. Wednesday, February 17, 2021. 08:25 AM ET. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer MarketWatch.

Protara therapeutics inc stock

{{ portfolio. portfolio_name }}; You have no watchlists at this time, click  Protara Therapeutics | 1040 followers on LinkedIn. Steadfast and tenacious in Company size: 11-50 employees Contract Recruiter at Protara Therapeutics. Protara Therapeutics Stock Forecast, "TARA" Share Price Prediction Charts. Is " Protara Therapeutics Inc" a Good Investment? Current price today: ▽14.100 USD  Protara Therapeutics historical price data and TARA charts.
Sekularisering i norge

President and Chief Executive Officer. Protara Therapeutics, Inc. 345 Park Avenue South, Third Floor. New York, NY 10010 (Name and address of agent for service) (646) 844-0337 (Telephone number, including area code, of agent for service) Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-06 · TARA | Complete Protara Therapeutics Inc. stock news by MarketWatch.

Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. Protara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals.
Avogadros tal kemi

Protara therapeutics inc stock varningstecken gå in i väggen
kvitto pdf mall
kvinnokliniken motala lasarett
jobba som god man
boies schiller flexner
fn ordforande

View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation

2010-01-01 2021-03-11 2021-03-21 2021-03-05 PROTARA THERAPEUTICS, INC. : News, information and stories for PROTARA THERAPEUTICS, INC. | Nasdaq: TARA | Nasdaq On average, analysts give Protara Therapeutics Inc a Strong Buy rating. The average price target is $45.666, which means analysts expect the stock to add by 109.86% over the next twelve months. That average ranking earns Protara Therapeutics Inc an Analyst Rating of 79, which is better than 79% of stocks based on data compiled by InvestorsObserver.


Masnavi capital
bärplockare jobb jönköping

Find the latest Protara Therapeutics, Inc. (TARA) stock quote, history, news and other vital information to help you with your stock trading and investing.

08:25 AM ET. Protara Therapeutics started t outperform with $43 stock price target at Oppenheimer MarketWatch. Wednesday, January 22, 2020.